Value Proposition & Evidence Strategy
A successful value proposition for all life sciences products -- including drugs, medical devices, and diagnostics -- must be accompanied by evidence of product value.
Analysis Group works with clients in all phases of development and commercialization to identify market access challenges, opportunities, and evidence-generation activities to support successful outcomes.
Our capabilities include:
- Landscape Assessment
Analysis of the competitive landscape, analogue assessments, and identification of evidence requirements - Gap Assessment
Evaluation of product attributes and opportunities for evidence generation, strength of supporting evidence, and opportunities to fill gaps - Value Proposition and Key Value Messages
Development of value proposition and key value messages, supported by evidence and research to gain an understanding of stakeholder needs - Strategic Plan
Development of detailed roadmap for evidence generation and communication of product value - Early-Phase Assessment of Comparative Effectiveness
Assessment of clinical and economic value versus alternatives in early phases, using modeling and simulation
